H.R. 1499: To prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable prod

Introduced: Sponsor: Rep. Bobby Rush [D-IL1]

This bill was referred to the House Committee on Energy and Commerce and House Committee on the Judiciary which will consider it before sending it to the House floor for consideration.

Rep. Bobby Rush [D-IL1] is a member of the House Committee on Energy and Commerce.